Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-000883

President sold 40,000 shares at $30.00 ($1,200,000)

  • President acquired 40,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

RUBINSTEIN JULIE · President

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-12-31 Exercise or conversion : show line 1 in the form +40,000 $0.84 $33,600 40,000 D
2019-12-31 Sale : show line 2 in the form −40,000 $30.00 $1,200,000 0 D
Open-market sales · 40,000 sh · avg $30.00 · $1,200,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-12-31 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −40,000 25,000 D
Loading xslF345X03/doc4.xml…